(19)
(11) EP 2 647 995 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.02.2015 Bulletin 2015/08

(45) Mention of the grant of the patent:
10.12.2014 Bulletin 2014/50

(21) Application number: 12162884.6

(22) Date of filing: 02.04.2012
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)

(54)

Methods and use for assessing chronic obstructive pulmonary disease (COPD) severity

Verfahren und Anwendung zur Beurteilung der Schwere einer chronisch obstruktiven Lungenerkrankung (COPD)

Procédés et utilisations pour évaluer la gravité d'une maladie pulmonaire obstructive chronique (COPD)

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43) Date of publication of application:
09.10.2013 Bulletin 2013/41

(73) Proprietors:
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)
    Designated Contracting States:
    DE 
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)
    Designated Contracting States:
    AL AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR 

(72) Inventors:
  • Horsch, Andrea
    68259 Mannheim (DE)
  • Gallusser, Andreas
    82377 Penzberg (DE)
  • Hess, Georg
    55130 Mainz (DE)
  • Klemt, Volker
    82362 Weilheim (DE)
  • Zdunek, Dietmar
    82327 Tutzing (DE)

(74) Representative: Schiweck, Weinzierl & Koch 
European Patent Attorneys Landsberger Straße 98
80339 München
80339 München (DE)


(56) References cited: : 
WO-A2-2006/097244
   
  • GRIESE MATTHIAS ET AL: "Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease", RESPIRATORY RESEARCH, BIOMED CENTRAL LTD., LONDON, GB, vol. 6, no. 80, 22 July 2005 (2005-07-22), pages 1-11, XP021000173, ISSN: 1465-9921, DOI: 10.1186/1465-9921-6-80
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).